Get started
Author

Bartosz Puła

Observed names: B. PULA, B. Pula, B. Puła, BARTOSZ PULA, BARTOSZ PUŁA, Bartosz Bartosz Puła, Bartosz Michal Pula, Bartosz PULA, Bartosz Pula, Bartoz Pula, Pula, Bartosz
Observed institutions: Poznan University of Medical Sciences, University of Wrocław, Wroclaw Medical University, Instytut Hematologii i Transfuzjologi, Wojewódzki Szpital Specjalistyczny we Wrocławiu, Copernicus Memorial Hospital, Medical University of Lodz, Wroclaw University of Health and Sport Sciences, St. Josef-Hospital, Ruhr University Bochum
ORCID: 0000-0003-0116-5002
Observed ORCID: 0000-0003-0116-5002
OpenAlex ID: A5046478756
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
2024 · Meletios A. Dimopoulos, Peter M. Voorhees, et al. · New England Journal of Medicine · 119
Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma
2011 · Bartosz Pula, Aleksandra Jethon, et al. · Histopathology · 99
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial
2023 · Dominik Dytfeld, Tomasz Wróbel, et al. · The Lancet Oncology · 81
PDF
Expression of melatonin receptor MT 1 in cells of human invasive ductal breast carcinoma
2012 · Karolina Jablonska, Bartosz Pula, et al. · Journal of Pineal Research · 70
Significance of podoplanin expression in cancer-associated fibroblasts: A comprehensive review
2013 · BARTOSZ PULA, WOJCIECH WITKIEWICZ, et al. · International Journal of Oncology · 67
PDF
Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients
2012 · Bozena Werynska, Bartosz Pula, et al. · Experimental and Molecular Pathology · 66
Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease
2010 · Larissa Arning, Aiden Haghikia, et al. · Journal of Molecular Medicine · 60
Galactosylceramide Affects Tumorigenic and Metastatic Properties of Breast Cancer Cells as an Anti-Apoptotic Molecule
2013 · Tomasz B. Owczarek, Jarosław Suchanski, et al. · PLoS ONE · 52
PDF
Correlation of intensity of MT-I/II expression with Ki-67 and MCM-2 proteins in invasive ductal breast carcinoma.
2011 · Andrzej Wojnar, Bartosz Pula, et al. · PubMed · 52
Overcoming Ibrutinib Resistance in Chronic Lymphocytic Leukemia
2019 · Bartosz Puła, Aleksandra Gołos, et al. · Cancers · 51
PDF
Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer.
2011 · Bozena Werynska, Bartosz Pula, et al. · PubMed · 48
PI3K Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Current Status and Future Perspectives
2022 · Iwona Hus, Bartosz Puła, et al. · Cancers · 45
PDF
Prognostic significance of SOX18 expression in non-small cell lung cancer
2014 · ALEKSANDRA JETHON, BARTOSZ PULA, et al. · International Journal of Oncology · 43
PDF
Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma
2013 · Bartosz Pula, Mateusz Olbromski, et al. · Cellular Oncology · 40
Outcomes of treatment with dose‐adjusted EPOCH‐R or R‐CHOP in primary mediastinal large B‐cell lymphoma
2019 · Agata Malenda, Agnieszka Kołkowska‐Leśniak, et al. · European Journal Of Haematology · 39
A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia
2018 · Wojciech Czardybon, Renata Windak, et al. · Oncotarget · 39
PDF
Metallothioneins in Normal and Cancer Cells
2016 · Piotr Dziegiel, Bartosz Pula, et al. · Advances in anatomy, embryology and cell biology · 39
Metallothionein-3 Increases Triple-Negative Breast Cancer Cell Invasiveness via Induction of Metalloproteinase Expression
2015 · Alicja M. Kmiecik, Bartosz Pula, et al. · PLoS ONE · 37
PDF
Mass spectrometry–based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma
2024 · Tadeusz Kubicki, Dominik Dytfeld, et al. · Blood · 35
Current Treatment of Chronic Lymphocytic Leukemia
2017 · Krzysztof Jamroziak, Bartosz Puła, et al. · Current Treatment Options in Oncology · 35
Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
2010 · Andrzej Wojnar, Christopher Kobierzycki, et al. · Folia Histochemica et Cytobiologica · 34
PDF
Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies
2021 · Maciej Szydłowski, Filip Garbicz, et al. · Cancer Research · 33
Expression of the MT1 Melatonin Receptor in Ovarian Cancer Cells
2014 · Karolina Jablonska, Bartosz Pula, et al. · International Journal of Molecular Sciences · 33
PDF
Introduction
2016 · Piotr Dziegiel, Bartosz Pula, et al. · Advances in anatomy, embryology and cell biology · 32
Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas
2015 · Marcin Nowak, Janusz A. Madej, et al. · Irish Veterinary Journal · 30
PDF
Works count: 236
Citation count: 2,602
H-index: 28
I10-index: 84
Year
Topic
Type